SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 1-K -
SEC Accession No. 0001213900-20-010304
Filing Date
2020-04-28
Accepted
2020-04-28 17:21:25
Documents
8
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 1-K  
1 primary_doc.xml 1-K 1401
2 ANNUAL REPORT PURSUANT TO REGULATION A ea121057-1k_emeraldhealth.htm PART II 486146
3 LOAN AGREEMENT BETWEEN THE COMPANY AND ROCKING HORSE NOMINEE PTY LTD ea121057ex6-10_emerald.htm EX1K-6 MAT CTRCT 251087
4 ESCROW SERVICES AGREEMENT DATED JULY 26, 2019 BETWEEN THE COMPANY AND PRIME TRUS ea121057ex8-1_emerald.htm EX1K-8 ESCW AGMT 53564
5 CONSENT OF DELOITTE & TOUCHE LLP ea121057ex11-1_emerald.htm EX1K-11 CONSENT 1379
6 GRAPHIC image_001.jpg GRAPHIC 53233
7 GRAPHIC image_002.jpg GRAPHIC 68119
8 GRAPHIC image_003.jpg GRAPHIC 22473
  Complete submission text file 0001213900-20-010304.txt   993192
Mailing Address 5910 PACIFIC CENTER BLVD SUITE 300, SAN DIEGO CA 92121
Business Address 5910 PACIFIC CENTER BLVD SUITE 300, SAN DIEGO CA 92121 (858) 352-0622
Emerald Health Pharmaceuticals Inc. (Filer) CIK: 0001700800 (see all company filings)

IRS No.: 820669961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 1-K | Act: 33 | File No.: 24R-00152 | Film No.: 20826235
SIC: 2834 Pharmaceutical Preparations